Opportunity Information: Apply for PAR 20 072
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is soliciting investigator-initiated Program Project Grant (P01) applications under funding opportunity PAR-20-072. This is a discretionary grant opportunity in the health funding activity category (CFDA 93.855). The central purpose is to support large, multi-project research programs that tackle important questions aligned with the NIAID mission, with an emphasis on coordinated, synergistic science rather than a collection of unrelated studies. Clinical trials are not allowed under this announcement, so the supported work should be basic, mechanistic, preclinical, or other non-clinical-trial research, potentially including translational efforts that do not meet the NIH definition of a clinical trial.
The scientific scope is broad but focused on infectious diseases, immunology, and allergy. Proposed programs may address the biology and pathogenesis of microbes and the host response to those microbes, explicitly including HIV. NIAID is also interested in research on how the immune system develops and functions under normal conditions, and how immune dysfunction contributes to diseases such as autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection. In addition, the FOA encourages translational research aimed at developing vaccines, therapeutics, and diagnostics to prevent or treat infectious, immune-mediated, and allergic diseases, as long as the work stays within the non-clinical-trial boundary set by the announcement.
A key structural requirement of this P01 mechanism is that each application must include at least two related research projects that share a common central theme, focus, and/or overall objective. In practice, this means the application should be built around a unifying scientific question or goal, with projects designed to complement one another and generate added value through collaboration, shared methods, shared resources, and coordinated leadership. A competitive P01 typically demonstrates that the combined program will achieve more than the same projects pursued independently, for example by integrating expertise across disciplines, sharing key cores or resources, or using findings from one project to drive experiments in another.
Eligibility is broad across U.S.-based organizations and governmental entities. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; certain non-federally recognized tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education when applying under those nonprofit categories); for-profit organizations other than small businesses; and small businesses. The FOA also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.
Foreign eligibility is restricted in a way that often matters for collaborations. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, meaning a U.S. applicant may include certain foreign elements within the project when justified and when compliant with NIH policy, even though a foreign institution cannot be the primary applicant.
The opportunity was created on 2019-12-09, and the listed original closing date in the provided source information is 2022-09-07. The award ceiling and expected number of awards are not specified in the source data you provided, which usually means applicants should rely on the FOA text and NIH policies to understand budget expectations, typical P01 scale, and any institute-specific limits or guidance. Overall, this FOA is best suited to teams that can propose a cohesive, multi-project research program tightly aligned with NIAID priorities in infectious disease and immunology, with clearly articulated synergy across at least two interrelated projects and no clinical trial activities.Apply for PAR 20 072
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855.
- This funding opportunity was created on 2019-12-09.
- Applicants must submit their applications by 2022-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
Previous opportunity: Clinical High Risk for Psychosis Research Network (U01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 20 072
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 20 072) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIDCR Predoctoral to Postdoctoral Transition Award for A Diverse Dental, Oral, and Craniofacial Research Workforce (F99/K00 Clinical Trial Not Allowed) Apply for PAR 20 069 Funding Number: PAR 20 069 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| CATALYTIC CHANGE FOR CROSS BORDER HEALTH Apply for RFI 720 623 001 Funding Number: RFI 720 623 001 Agency: Kenya USAID-Nairobi Category: Health Funding Amount: $10,000,000 |
| Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R21 Clinical Trial Not Allowed) Apply for RFA MH 20 331 Funding Number: RFA MH 20 331 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R01 Clinical Trial Optional) Apply for RFA MH 20 330 Funding Number: RFA MH 20 330 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed) Apply for RFA AG 21 010 Funding Number: RFA AG 21 010 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed) Apply for RFA AG 21 002 Funding Number: RFA AG 21 002 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) Apply for RFA AI 19 072 Funding Number: RFA AI 19 072 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 20 078 Funding Number: PAR 20 078 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition 4DN Data Coordination and Integration Center (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 008 Funding Number: RFA RM 20 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: 4DN Organizational Hub (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 007 Funding Number: RFA RM 20 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Surgical Disparities Research (R01 - Clinical Trial Optional) Apply for PAR 20 079 Funding Number: PAR 20 079 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) Apply for PAR 20 084 Funding Number: PAR 20 084 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) Apply for PAR 20 037 Funding Number: PAR 20 037 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) Apply for RFA OD 20 002 Funding Number: RFA OD 20 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) Apply for PAR 20 038 Funding Number: PAR 20 038 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| MoTrPAc Phase 2 Animal Studies (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 009 Funding Number: RFA RM 20 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Infrastructure for the Expansion of Rhesus macaque Colonies to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed) Apply for PAR 20 087 Funding Number: PAR 20 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 20 086 Funding Number: PAR 20 086 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mendelian Genomics Research Centers (U01 Clinical Trial Optional) Apply for RFA HG 20 007 Funding Number: RFA HG 20 007 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Central and Peripheral Control of Balance in Older Adults (R01 Clinical Trial Optional) Apply for RFA AG 21 011 Funding Number: RFA AG 21 011 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 20 072", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
